JAK/STAT signaling plays a major role in the pathogenesis of secondary hemophagocytic lymphohistiocytosis. This case report on a critically ill patient with secondary hemophagocytic lymphohistiocytosis due to falciparum malaria treated successfully with ruxolitinib, demonstrates that JAK1/2 inhibition might be a promising treatment option for severe cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijid.2020.07.062 | DOI Listing |
Publication Analysis
Top Keywords
secondary hemophagocytic
12
hemophagocytic lymphohistiocytosis
12
treated ruxolitinib
8
falciparum malaria-induced
4
malaria-induced secondary
4
lymphohistiocytosis treated
4
ruxolitinib jak/stat
4
jak/stat signaling
4
signaling plays
4
plays major
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!